BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21594859)

  • 1. [Glial stem cells and their relationship with tumour angiogenesis process].
    Bulnes S; García-Blanco Á; Bengoetxea H; Ortuzar N; Argandoña EG; Lafuente JV
    Rev Neurol; 2011 Jun; 52(12):743-50. PubMed ID: 21594859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the origin and growth of gliomas.
    Schiffer D; Annovazzi L; Caldera V; Mellai M
    Anticancer Res; 2010 Jun; 30(6):1977-98. PubMed ID: 20651342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.
    Salmaggi A; Boiardi A; Gelati M; Russo A; Calatozzolo C; Ciusani E; Sciacca FL; Ottolina A; Parati EA; La Porta C; Alessandri G; Marras C; Croci D; De Rossi M
    Glia; 2006 Dec; 54(8):850-60. PubMed ID: 16981197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133 identifies perivascular niches in grade II-IV astrocytomas.
    Christensen K; Schrøder HD; Kristensen BW
    J Neurooncol; 2008 Nov; 90(2):157-70. PubMed ID: 18612800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms.
    Schittenhelm J; Simon P; Harter PN; Zachskorn C; Schlaszus H; Röttger F; Winkels M; Weller M; Meyermann R; Mittelbronn M
    Histopathology; 2011 Apr; 58(5):739-49. PubMed ID: 21438906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the clinical value of cancer stem cell markers in gliomas?
    Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
    Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
    Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and partial characterization of a new human glioblastoma cell line.
    Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
    Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
    Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
    J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell markers in gliomas.
    Dell'Albani P
    Neurochem Res; 2008 Dec; 33(12):2407-15. PubMed ID: 18493853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
    Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
    Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+ and Nestin+ Glioma Stem-Like Cells Reside Around CD31+ Arterioles in Niches that Express SDF-1α, CXCR4, Osteopontin and Cathepsin K.
    Hira VV; Ploegmakers KJ; Grevers F; Verbovšek U; Silvestre-Roig C; Aronica E; Tigchelaar W; Turnšek TL; Molenaar RJ; Van Noorden CJ
    J Histochem Cytochem; 2015 Jul; 63(7):481-93. PubMed ID: 25809793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.